SCHEMBL1381950

SCHEMBL1381950

CC(=O)NCCNc1cccc(CC(c2cccnc2)(c2cccnc2)c2cccc(C#N)c2)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.42
CYP3A4 P08684 5/20 0.42
CLK4 Q9HAZ1 5/20 0.42
USP2 O75604 1/20 0.42
CYP2D6 P10635 1/20 0.42
GRM5 P41594 3/20 0.37
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 3/20 0.36
VNN1 O95497 3/20 0.36
TSHR P16473 2/20 0.36
ALOX15 P16050 2/20 0.36
MAPK1 P28482 2/20 0.36
CYP2C19 P33261 1/20 0.36
PTGER2 P43116 4/20 0.36
SCD O00767 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
CFTR P13569 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1378017 0.88 GRM5 (0.43) CYP1A2GRM5VNN1
SCHEMBL3818100 0.86 CLK4 (0.36) CYP1A2CYP3A4CLK4GRM5ALDH1A1
SCHEMBL3815565 0.83 PTGER2 (0.41) CYP1A2CYP3A4CLK4GRM5ALDH1A1
SCHEMBL3819011 0.81 HSD11B1 (0.39) CYP1A2CYP3A4CLK4GRM5ALDH1A1
SCHEMBL1378033 0.76 KCNA5 (0.43) CYP3A4PTGER2
SCHEMBL1379275 0.75 PTGER2 (0.38) PTGER2
SCHEMBL3816028 0.74 PTGER2 (0.39) PTGER2
SCHEMBL1382204 0.74 SMN1; SMN2 (0.42) CYP3A4GRM5ALDH1A1MAPK1
SCHEMBL1381946 0.74 KCNA5 (0.43) CYP1A2CYP3A4CLK4USP2CYP2D6
SCHEMBL1376732 0.72 VNN1 (0.39) CYP3A4GRM5VNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4719744-B2 2011-07-06 JP claimed
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP claimed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP claimed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO claimed
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP disclosed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP disclosed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO disclosed